Fate Therapeutics Inc. buy BiotechBee
Start price
26.10.22
/
70%
€20.67
Target price
31.12.24
€35.00
Performance (%)
-41.33%
End price
21.12.22
€12.12
Summary
This prediction ended on 21.12.22 with a price of €12.12. Massive losses of -41.33% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | 8.603% | 8.603% | -36.084% | -82.803% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
According to BiotechBee what are the pros and cons of Fate Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Buy mit Kursziel 35,0